Literature DB >> 19910911

Update: influenza activity - United States, August 30-October 31, 2009.

.   

Abstract

The 2009 pandemic influenza A (H1N1) virus emerged in the United States in April 2009 and has since spread worldwide. Influenza activity resulting from this virus occurred throughout the summer and, by late August, activity had begun to increase in the southeastern United States. Since August, activity has increased in all regions of the United States. As of the week ending October 31, nearly all states were reporting widespread disease. Since April 2009, pandemic H1N1 has remained the dominant circulating influenza strain. This report summarizes U.S. influenza activity from August 30, 2009, defined as the beginning of the 2009-10 influenza season, through October 31, 2009.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910911

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  20 in total

1.  Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations.

Authors:  Saeyoung Park; Moon H Nahm
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

2.  Emergency department visits for antiviral adverse events during the 2009 H1N1 influenza pandemic.

Authors:  Maribeth C Lovegrove; Nadine Shehab; Craig M Hales; Kathy Poneleit; Elizabeth Crane; Daniel S Budnitz
Journal:  Public Health Rep       Date:  2011 May-Jun       Impact factor: 2.792

Review 3.  Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies.

Authors:  Zhengtu Li; Li Li; Shuai Zhao; Jing Li; Hongxia Zhou; Yunhui Zhang; Zifeng Yang; Bing Yuan
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

4.  Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009.

Authors:  Melissa Helferty; Julie Vachon; Jill Tarasuk; Rachel Rodin; John Spika; Louise Pelletier
Journal:  CMAJ       Date:  2010-11-08       Impact factor: 8.262

5.  Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets.

Authors:  Matthew J Memoli; A Sally Davis; Kathleen Proudfoot; Daniel S Chertow; Rachel J Hrabal; Tyler Bristol; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2010-12-20       Impact factor: 5.226

6.  A survey of emergency department 2009 pandemic influenza A (H1N1) surge preparedness--Atlanta, Georgia, July-October 2009.

Authors:  David Sugerman; Kelly H Nadeau; Kathryn Lafond; Wendy Cameron; Karl Soetebier; Michael Jhung; Alexander Isakov; Ian Greenwald; Karen Neil; Stephanie Schrag; Alicia Fry
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

Review 7.  Drugs in development for influenza.

Authors:  David A Boltz; Jerry R Aldridge; Robert G Webster; Elena A Govorkova
Journal:  Drugs       Date:  2010-07-30       Impact factor: 9.546

8.  Pandemic influenza: implications for preparation and delivery of critical care services.

Authors:  Mary-Elise Manuell; Mary Dawn T Co; Richard T Ellison
Journal:  J Intensive Care Med       Date:  2011-01-10       Impact factor: 3.510

9.  Employer-incurred health care costs and productivity losses associated with influenza.

Authors:  Sudeep Karve; Derek A Misurski; Genevieve Meier; Keith L Davis
Journal:  Hum Vaccin Immunother       Date:  2013-01-15       Impact factor: 3.452

10.  Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 Influenza Viruses using a pseudotype neutralization assay.

Authors:  Béatrice Labrosse; Mathieu Tourdjman; Raphaël Porcher; Jérôme LeGoff; Xavier de Lamballerie; François Simon; Jean-Michel Molina; François Clavel
Journal:  PLoS One       Date:  2010-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.